Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • Low profitability weakens the company.
  • One of the major weak points of the company is its financial situation.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • Based on current prices, the company has particularly high valuation levels.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The underlying tendency is negative on the weekly chart below the resistance at 137 GBp
Ratings chart
Subsector Biotechnology & Medical Research - NEC
1st jan.Capitalisation (M$)Investor Rating
PURETECH HEALTH PLC1.80%369
INCYTE CORPORATION38.04%27 518
QUINTILES IMS HOLDINGS INC11.37%18 872
LONZA GROUP AG23.45%15 703
CELLTRION, INC.--.--%10 293
SEATTLE GENETICS, INC.25.11%9 358
ALKERMES PLC4.25%8 839
QIAGEN NV13.07%7 594
ALNYLAM PHARMACEUTICALS, IN..85.63%6 020
IONIS PHARMACEUTICALS INC-3.09%5 750
UNITED THERAPEUTICS CORPORA..-17.49%5 366
Autres valeurs du secteur
Company
Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmunePureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness,... 
More about the company
Advertisement
Financials ($)
Sales 2017 1,85 M
EBIT 2017 -100 M
Net income 2017 -66,8 M
Debt 2017 2,93 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 201x
EV / Sales 2018 184x
Capitalization 369 M
More Financials
Chart PURETECH HEALTH PLC
Duration : Period : Day
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Duration : Period : Week
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Surperformance© ratings  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision -
4 months EPS revision -
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
More Ratings